435 related articles for article (PubMed ID: 22709007)
1. Role of oxidative stress and molecular changes in liver fibrosis: a review.
Sánchez-Valle V; Chávez-Tapia NC; Uribe M; Méndez-Sánchez N
Curr Med Chem; 2012; 19(28):4850-60. PubMed ID: 22709007
[TBL] [Abstract][Full Text] [Related]
2. Targeting Oxidative Stress for the Treatment of Liver Fibrosis.
Luangmonkong T; Suriguga S; Mutsaers HAM; Groothuis GMM; Olinga P; Boersema M
Rev Physiol Biochem Pharmacol; 2018; 175():71-102. PubMed ID: 29728869
[TBL] [Abstract][Full Text] [Related]
3. Role of NADPH oxidases in the redox biology of liver fibrosis.
Crosas-Molist E; Fabregat I
Redox Biol; 2015 Dec; 6():106-111. PubMed ID: 26204504
[TBL] [Abstract][Full Text] [Related]
4. Oxidative and nitrosative stress and fibrogenic response.
Urtasun R; Conde de la Rosa L; Nieto N
Clin Liver Dis; 2008 Nov; 12(4):769-90, viii. PubMed ID: 18984466
[TBL] [Abstract][Full Text] [Related]
5. Fighting Liver Fibrosis with Naturally Occurring Antioxidants.
Lin L; Zhou F; Shen S; Zhang T
Planta Med; 2018 Dec; 84(18):1318-1333. PubMed ID: 30312974
[TBL] [Abstract][Full Text] [Related]
6. Research progress of natural compounds in anti-liver fibrosis by affecting autophagy of hepatic stellate cells.
Shu Y; Liu X; Huang H; Wen Q; Shu J
Mol Biol Rep; 2021 Feb; 48(2):1915-1924. PubMed ID: 33609264
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms in the pathogenesis of N-nitrosodimethylamine induced hepatic fibrosis.
George J; Tsuchishima M; Tsutsumi M
Cell Death Dis; 2019 Jan; 10(1):18. PubMed ID: 30622238
[TBL] [Abstract][Full Text] [Related]
8. Melatonin protects against lipid-induced mitochondrial dysfunction in hepatocytes and inhibits stellate cell activation during hepatic fibrosis in mice.
Das N; Mandala A; Naaz S; Giri S; Jain M; Bandyopadhyay D; Reiter RJ; Roy SS
J Pineal Res; 2017 May; 62(4):. PubMed ID: 28247434
[TBL] [Abstract][Full Text] [Related]
9. α-Lipoic acid inhibits liver fibrosis through the attenuation of ROS-triggered signaling in hepatic stellate cells activated by PDGF and TGF-β.
Foo NP; Lin SH; Lee YH; Wu MJ; Wang YJ
Toxicology; 2011 Mar; 282(1-2):39-46. PubMed ID: 21251946
[TBL] [Abstract][Full Text] [Related]
10. Role of cytoglobin, a novel radical scavenger, in stellate cell activation and hepatic fibrosis.
Thuy LTT; Hai H; Kawada N
Clin Mol Hepatol; 2020 Jul; 26(3):280-293. PubMed ID: 32492766
[TBL] [Abstract][Full Text] [Related]
11. Reversal of liver cirrhosis: current evidence and expectations.
Jung YK; Yim HJ
Korean J Intern Med; 2017 Mar; 32(2):213-228. PubMed ID: 28171717
[TBL] [Abstract][Full Text] [Related]
12. Nuclear erythroid 2-related factor 2: a novel potential therapeutic target for liver fibrosis.
Yang JJ; Tao H; Huang C; Li J
Food Chem Toxicol; 2013 Sep; 59():421-7. PubMed ID: 23793039
[TBL] [Abstract][Full Text] [Related]
13. ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis.
Foglia B; Cannito S; Bocca C; Parola M; Novo E
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31159366
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of redox pathways in liver fibrosis.
Torok NJ
Am J Physiol Gastrointest Liver Physiol; 2016 Oct; 311(4):G667-G674. PubMed ID: 27562057
[TBL] [Abstract][Full Text] [Related]
15. Free radicals, antioxidants, nuclear factor-E2-related factor-2 and liver damage.
Ramos-Tovar E; Muriel P
Vitam Horm; 2023; 121():271-292. PubMed ID: 36707137
[TBL] [Abstract][Full Text] [Related]
16. Liver fibrosis: from the bench to clinical targets.
Pinzani M; Rombouts K
Dig Liver Dis; 2004 Apr; 36(4):231-42. PubMed ID: 15115333
[TBL] [Abstract][Full Text] [Related]
17. Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress.
Yang JH; Kim SC; Kim KM; Jang CH; Cho SS; Kim SJ; Ku SK; Cho IJ; Ki SH
Eur J Pharmacol; 2016 Jul; 783():92-102. PubMed ID: 27151496
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of hydrogen sulfide on oxidative stress and fibrosis in hepatic stellate cells.
Fan HN; Wang HJ; Yang-Dan CR; Ren L; Wang C; Li YF; Deng Y
Mol Med Rep; 2013 Jan; 7(1):247-53. PubMed ID: 23129058
[TBL] [Abstract][Full Text] [Related]
19. Ligustrazine attenuates oxidative stress-induced activation of hepatic stellate cells by interrupting platelet-derived growth factor-β receptor-mediated ERK and p38 pathways.
Zhang F; Ni C; Kong D; Zhang X; Zhu X; Chen L; Lu Y; Zheng S
Toxicol Appl Pharmacol; 2012 Nov; 265(1):51-60. PubMed ID: 23022513
[TBL] [Abstract][Full Text] [Related]
20. Astragaloside IV suppresses collagen production of activated hepatic stellate cells via oxidative stress-mediated p38 MAPK pathway.
Li X; Wang X; Han C; Wang X; Xing G; Zhou L; Li G; Niu Y
Free Radic Biol Med; 2013 Jul; 60():168-76. PubMed ID: 23459070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
